Nigeria's leading teaching hospital in its largest city, home of the NSIA-LUTH Cancer Centre, the country's most advanced radiotherapy facility.
Lagos University Teaching Hospital was founded in 1962 as the teaching hospital of the University of Lagos College of Medicine and is one of Nigeria's foremost tertiary hospitals. In 2019 it opened the NSIA-LUTH Cancer Centre, a public-private partnership with the Nigeria Sovereign Investment Authority that brought multiple linear accelerators and brachytherapy to a country that had long suffered from broken radiotherapy machines, making it West Africa's most advanced radiotherapy centre alongside chemotherapy and surgical oncology services. LUTH researchers contribute to studies of breast cancer in Nigerian women (including the genetic work with the University of Chicago showing high rates of aggressive and hereditary disease), prostate cancer, cervical cancer screening and paediatric oncology, and the hospital hosts oncology fellowship training for Nigeria.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Lagos University Teaching Hospital, including child institutions. 62 works · 1,335 citations · 77% open access · 2% clinical trials · 5% reviews.
Shares Cancer health disparities and equity, Global oncology and access in low- and middle-income countries, Brachytherapy, Germline (hereditary) testing.
Shares Cancer health disparities and equity, Global oncology and access in low- and middle-income countries, Brachytherapy, Germline (hereditary) testing.
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, Cervical cancer, IMRT / IGRT (modern external beam).
Shares Cancer health disparities and equity, Global oncology and access in low- and middle-income countries, Cervical cancer, IMRT / IGRT (modern external beam).
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, Cervical cancer, IMRT / IGRT (modern external beam).
Shares BRCA1 / BRCA2 (HRD), Germline (hereditary) testing, IMRT / IGRT (modern external beam), Triple-negative breast cancer (TNBC).
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, Cervical cancer, IMRT / IGRT (modern external beam).
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, Cervical cancer, IMRT / IGRT (modern external beam).